NivaarExam PrepOfficial exam papers ↗

20-Bio-A3 Biomechanics · December 2018

Question 4 of 6: Gene Regulation and Cell Differentiation

Nivaar worked solution (AI-drafted; not reviewed by a licensed engineer)

Notes on this paper

National Exams — December 2018 — 04-Bio-A3, Cellular and Molecular Biology and Biochemistry. Three-hour, CLOSED-BOOK exam; only an approved Casio or Sharp calculator is permitted. The paper carries six questions of equal value (20 marks each): FIVE questions constitute a complete paper and only the first five as they appear in the answer book are marked (100 marks total), with candidates urged to state any interpretive assumptions in writing. All SIX questions are worked below as a complete study resource. Question 6 is a 20-item True/False set marked +1 for a correct answer, 0 for a blank, and −1 for an incorrect answer.

Reference texts: Alberts et al., Molecular Biology of the Cell (6th ed.) — cell structure, gene regulation, DNA/RNA/protein synthesis; Nelson & Cox, Lehninger Principles of Biochemistry (7th ed.) — enzyme kinetics, Michaelis–Menten and substrate inhibition; Sambrook & Russell, Molecular Cloning: A Laboratory Manual (4th ed.) — restriction mapping, Sanger sequencing; Murphy & Weaver, Janeway's Immunobiology (9th ed.) — antibody structure and function; Murray et al., Medical Microbiology (9th ed.) — antibiotic mechanisms and susceptibility testing.

Question 4: Gene Regulation and Cell Differentiation (20 marks)

Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.

(a) Gene-regulatory "state" — which genes are transcriptionally active versus silenced in a given cell — is passed from a parent cell to its daughter cells without any change to the underlying DNA sequence, through heritable chemical marks on the DNA and its associated chromatin, collectively called epigenetic modifications. The two principal mechanisms are: (1) DNA methylation, the covalent addition of a methyl group to cytosine (predominantly at CpG dinucleotides) by DNA methyltransferases; when DNA replicates, the result is "hemimethylated" DNA (methylated on the old parental strand, unmethylated on the newly synthesized strand), and a maintenance methyltransferase (DNMT1) specifically recognizes this hemimethylated state and methylates the new strand to match the parental pattern — this is directly analogous to semi-conservative DNA replication and propagates the SAME methylation pattern to both daughter DNA duplexes with high fidelity. (2) Histone modifications (e.g. acetylation, methylation, phosphorylation of specific histone tail residues) alter chromatin packing state — acetylation generally loosens chromatin (euchromatin, transcriptionally permissive) while certain methylation marks (e.g. H3K9me3) promote tight packing (heterochromatin, transcriptionally silent); these marks are propagated less exactly than DNA methylation (parental histones are distributed to both daughter DNA strands during replication, and "reader-writer" enzyme complexes that recognize an existing mark on a nearby nucleosome recruit the same modifying enzyme to re-establish it on newly deposited nucleosomes), but the net effect is still a reasonably faithful, heritable propagation of the chromatin state region-by-region. Neither mechanism changes the DNA sequence (genotype); both determine which genes are ACCESSIBLE to the transcriptional machinery, so they control the epigenetically-encoded gene-expression program independently of genotype. Relation to differentiation: as a stem/progenitor cell commits to a lineage, it establishes a stable, cell-type-specific pattern of DNA methylation and histone marks — permanently silencing genes for alternative fates (e.g. muscle-specific genes in a future neuron) while keeping the appropriate lineage genes accessible. Because these marks are then faithfully copied to every daughter cell at each subsequent division (via the mechanisms above), the differentiated identity is stably maintained through repeated cell division without requiring the original differentiation signal to be present continuously — this is precisely why a liver cell's mitotic progeny are liver cells, not some other cell type, even though every cell in the body carries an identical genome.

(b) A positive feedback loop is a regulatory circuit in which the output of a process reinforces (increases) its own input, rather than counteracting it as in negative feedback. In a gene-regulatory context, the classic form is a transcription factor (TF) whose own gene contains a binding site for that same TF in its promoter/enhancer, so that once even a small amount of the TF is produced, it binds its own gene and drives further transcription of itself — auto-activation. This creates a bistable switch: below a threshold level of TF, the loop stays off (low expression persists), but once an inducing signal pushes TF concentration above the threshold, the auto-activation loop becomes self-sustaining and keeps TF expression high even after the original inducing signal is removed. Applied to cellular differentiation, master regulatory transcription factors that commit a cell to a specific lineage (e.g. MyoD in skeletal-muscle differentiation, or the core pluripotency factors discussed in part c) frequently auto-activate and also cross-activate a whole network of other lineage-specific genes; this converts what might otherwise be a transient external inductive signal into a permanent, self-reinforcing, and heritable (part a) commitment to that differentiated state — positive feedback is therefore the molecular mechanism that makes cellular differentiation a stable, largely irreversible decision rather than a reversible response that would revert as soon as the inducing signal disappeared.

(c) Induced pluripotent stem (iPS) cells are adult, already-differentiated somatic cells that have been experimentally reprogrammed back into an embryonic-stem-cell-like pluripotent state, capable of differentiating into cell types from all three embryonic germ layers. Reprogramming is achieved by forcing expression of a small, defined set of transcription factors in the somatic cell — the original "Yamanaka factors" Oct4, Sox2, Klf4 and c-Myc — typically delivered by viral transduction (or safer non-integrating methods in more recent protocols). These factors drive a genome-wide erasure and resetting of the cell's existing epigenetic marks (the DNA methylation and histone modifications from part a that had locked in its differentiated identity), re-establishing an embryonic-stem-cell-like open chromatin/gene-expression state and re-activating the endogenous pluripotency network (including the cell's own Oct4/Sox2/Nanog genes, which then sustain the pluripotent state through the same kind of auto-activating positive feedback loop described in part b). Because iPS cells are derived directly from a patient's own adult cells (e.g. skin fibroblasts or blood cells) rather than from an embryo, they avoid the ethical and immune-rejection concerns associated with embryonic stem cells, and they are widely used for regenerative medicine research, patient-specific disease modeling, and drug screening.